ANDA 84401, held by Watson Labs. Testosterone Cypionate.
As of Nov 16, 2026, ANDA 84401 (Testosterone Cypionate), held by Watson Labs, was not approved, with 0 approved supplements and 0 published complete response letters.
| Testosterone Cypionate100MG/ML · injectable;injection | Testosterone Cypionate | Discontinued |
| Testosterone Cypionate200MG/ML · injectable;injection | Testosterone Cypionate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters